{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T06:34:54Z","timestamp":1781159694787,"version":"3.54.1"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005317","name":"Kermanshah University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005317","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.cellsig.2022.110248","type":"journal-article","created":{"date-parts":[[2022,1,15]],"date-time":"2022-01-15T11:14:00Z","timestamp":1642245240000},"page":"110248","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["MT2-MMP is differentially expressed in multiple myeloma cells and mediates their growth and progression"],"prefix":"10.1016","volume":"92","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1524-1697","authenticated-orcid":false,"given":"Shohreh","family":"Fakhari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Jalili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahram","family":"Nikkhoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bayazid","family":"Ghaderi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Amin","family":"Boshagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sako","family":"Mirzaie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Moradzad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cellsig.2022.110248_bb0005","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.mayocp.2015.11.007","article-title":"Multiple myeloma: diagnosis and treatment","volume":"91","author":"Rajkumar","year":"2016","journal-title":"Mayo Clin. Proc."},{"issue":"3","key":"10.1016\/j.cellsig.2022.110248_bb0010","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/nrclinonc.2012.15","article-title":"Latest advances and current challenges in the treatment of multiple myeloma","volume":"9","author":"Mahindra","year":"2012","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.cellsig.2022.110248_bb0015","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1182\/blood-2003-11-3839","article-title":"Osteoclasts enhance myeloma cell growth and survival via cell-cell contact: a vicious cycle between bone destruction and myeloma expansion","volume":"104","author":"Abe","year":"2004","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.cellsig.2022.110248_bb0020","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/imr.12233","article-title":"Targeting the bone marrow microenvironment in multiple myeloma","volume":"263","author":"Kawano","year":"2015","journal-title":"Immunol. Rev."},{"issue":"4","key":"10.1016\/j.cellsig.2022.110248_bb0025","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1182\/blood.V90.4.1649","article-title":"Metalloproteinases in multiple myeloma: production of matrix metalloproteinase-9 (MMP-9), activation of proMMP-2, and induction of MMP-1 by myeloma cells","volume":"90","author":"Barille","year":"1997","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.cellsig.2022.110248_bb0030","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1172\/JCI80276","article-title":"Multiple myeloma-derived MMP-13 mediates osteoclast fusogenesis and osteolytic disease","volume":"126","author":"Fu","year":"2016","journal-title":"J. Clin. Invest."},{"issue":"26","key":"10.1016\/j.cellsig.2022.110248_bb0035","doi-asserted-by":"crossref","first-page":"41827","DOI":"10.18632\/oncotarget.18103","article-title":"Selective inhibition of matrix metalloproteinase-2 in the multiple myeloma-bone microenvironment","volume":"8","author":"Shay","year":"2017","journal-title":"Oncotarget"},{"issue":"10","key":"10.1016\/j.cellsig.2022.110248_bb0040","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1111\/febs.12179","article-title":"Cell-surface serglycin promotes adhesion of myeloma cells to collagen type I and affects the expression of matrix metalloproteinases","volume":"280","author":"Skliris","year":"2013","journal-title":"FEBS J."},{"issue":"6","key":"10.1016\/j.cellsig.2022.110248_bb0045","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1158\/1535-7163.MCT-17-0646","article-title":"Matrix metalloproteinase inhibitors in cancer therapy: turning past failures into future successes","volume":"17","author":"Winer","year":"2018","journal-title":"Mol. Cancer Ther."},{"issue":"3","key":"10.1016\/j.cellsig.2022.110248_bb0050","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.cardiores.2005.12.002","article-title":"Structure and function of matrix metalloproteinases and TIMPs","volume":"69","author":"Nagase","year":"2006","journal-title":"Cardiovasc. Res."},{"issue":"6","key":"10.1016\/j.cellsig.2022.110248_bb0055","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1158\/0008-5472.CAN-09-3515","article-title":"Matrix metalloproteinases contribute distinct roles in neuroendocrine prostate carcinogenesis, metastasis, and angiogenesis progression","volume":"70","author":"Littlepage","year":"2010","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.cellsig.2022.110248_bb0060","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/path.1876","article-title":"Role of metalloproteinases MMP-9 and MT1-MMP in CXCL12-promoted myeloma cell invasion across basement membranes","volume":"208","author":"Parmo-Cabanas","year":"2006","journal-title":"J. Pathol."},{"issue":"13","key":"10.1016\/j.cellsig.2022.110248_bb0065","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1016\/j.ejca.2008.06.031","article-title":"VEGF release by MMP-9 mediated heparan sulphate cleavage induces colorectal cancer angiogenesis","volume":"44","author":"Hawinkels","year":"2008","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.cellsig.2022.110248_bb0070","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s00240-004-0440-8","article-title":"Matrix metalloproteinases as diagnostic (MMP-13) and prognostic (MMP-2, MMP-9) markers of prostate cancer","volume":"33","author":"Morgia","year":"2005","journal-title":"Urol. Res."},{"key":"10.1016\/j.cellsig.2022.110248_bb0075","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.matbio.2015.03.004","article-title":"Membrane-type matrix metalloproteinases: their functions and regulations","volume":"44\u201346","author":"Itoh","year":"2015","journal-title":"Matrix Biol."},{"issue":"19","key":"10.1016\/j.cellsig.2022.110248_bb0080","doi-asserted-by":"crossref","first-page":"13053","DOI":"10.1074\/jbc.M709327200","article-title":"The second dimer interface of MT1-MMP, the transmembrane domain, is essential for ProMMP-2 activation on the cell surface","volume":"283","author":"Itoh","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"36","key":"10.1016\/j.cellsig.2022.110248_bb0085","doi-asserted-by":"crossref","first-page":"26528","DOI":"10.1074\/jbc.M603331200","article-title":"TIMP independence of matrix metalloproteinase (MMP)-2 activation by membrane type 2 (MT2)-MMP is determined by contributions of both the MT2-MMP catalytic and hemopexin C domains","volume":"281","author":"Morrison","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.cellsig.2022.110248_bb0090","doi-asserted-by":"crossref","DOI":"10.3390\/ph12020077","article-title":"The expanding role of MT1-MMP in cancer progression","volume":"12","author":"Knapinska","year":"2019","journal-title":"Pharmaceuticals (Basel)"},{"issue":"2","key":"10.1016\/j.cellsig.2022.110248_bb0095","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.bbrc.2010.01.105","article-title":"The role of MT2-MMP in cancer progression","volume":"393","author":"Ito","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.cellsig.2022.110248_bb0100","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1177\/172460081002500202","article-title":"Prognostic value of membrane type 1 and 2 matrix metalloproteinase expression and gelatinase a activity in bladder cancer","volume":"25","author":"Mohammad","year":"2010","journal-title":"Int. J. Biol. Markers"},{"issue":"6","key":"10.1016\/j.cellsig.2022.110248_bb0105","first-page":"3469","article-title":"MT2-MMP expression associates with tumor progression and angiogenesis in human lung cancer","volume":"7","author":"Chen","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"2","key":"10.1016\/j.cellsig.2022.110248_bb0110","first-page":"1985","article-title":"Increased MT2-MMP expression in gastric cancer patients is associated with poor prognosis","volume":"8","author":"Xu","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"6","key":"10.1016\/j.cellsig.2022.110248_bb0115","doi-asserted-by":"crossref","first-page":"10613","DOI":"10.1002\/jcb.28351","article-title":"The prognostic value of matrix metalloproteinase-7 and matrix metalloproteinase-15 in acute myeloid leukemia","volume":"120","author":"Wu","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.cellsig.2022.110248_bb0120","article-title":"Designing new generation of potent inhibitors against membrane-type matrix metalloproteinase-2: a computational effort against multiple myeloma","volume":"1\u201313","author":"Fakhari","year":"2019","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"9","key":"10.1016\/j.cellsig.2022.110248_bb0125","first-page":"1234","article-title":"The phenotype of normal, reactive and malignant plasma cells. Identification of \"many and multiple myelomas\" and of new targets for myeloma therapy","volume":"91","author":"Bataille","year":"2006","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.cellsig.2022.110248_bb0130","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/cyto.a.10072","article-title":"Intracellular phospho-protein staining techniques for flow cytometry: monitoring single cell signaling events","volume":"55","author":"Krutzik","year":"2003","journal-title":"Cytometry Part A"},{"issue":"6","key":"10.1016\/j.cellsig.2022.110248_bb0135","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s00418-016-1426-7","article-title":"A microwave antigen retrieval method using two heating steps for enhanced immunostaining on aldehyde-fixed paraffin-embedded tissue sections","volume":"145","author":"Gu","year":"2016","journal-title":"Histochem. Cell Biol."},{"key":"10.1016\/j.cellsig.2022.110248_bb0140","series-title":"Nuclear Pattern of CXCR4 Expression Is Associated with a Better Overall Survival in Patients with Gastric Cancer","first-page":"808012","volume":"2014","author":"Nikkhoo","year":"2014"},{"key":"10.1016\/j.cellsig.2022.110248_bb0145","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4103\/2277-9175.124650","article-title":"Effect of helicobacter pylori infection on stromal-derived factor-1\/CXCR4 axis in bone marrow-derived mesenchymal stem cells","volume":"3","author":"Fakhari","year":"2014","journal-title":"Adv. Biomed. Res."},{"issue":"6","key":"10.1016\/j.cellsig.2022.110248_bb0150","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative C(T) method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat. Protoc."},{"issue":"3","key":"10.1016\/j.cellsig.2022.110248_bb0155","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1021\/pr1011476","article-title":"Coomassie staining as loading control in Western blot analysis","volume":"10","author":"Welinder","year":"2011","journal-title":"J. Proteome Res."},{"issue":"4","key":"10.1016\/j.cellsig.2022.110248_bb0160","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/cgt.2016.4","article-title":"Precise and efficient siRNA design: a key point in competent gene silencing","volume":"23","author":"Fakhr","year":"2016","journal-title":"Cancer Gene Ther."},{"issue":"5","key":"10.1016\/j.cellsig.2022.110248_bb0165","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1089\/nat.2014.0494","article-title":"Effect of siRNA with an asymmetric RNA\/dTdT overhang on RNA interference activity","volume":"24","author":"Park","year":"2014","journal-title":"Nucl. Acid Ther."},{"issue":"4","key":"10.1016\/j.cellsig.2022.110248_bb0170","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.4049\/jimmunol.167.4.1857","article-title":"Cutting edge: T cell migration regulated by CXCR4 chemokine receptor signaling to ZAP-70 tyrosine kinase","volume":"167","author":"Ottoson","year":"2001","journal-title":"J. Immunology (Baltimore, Md : 1950)"},{"issue":"5","key":"10.1016\/j.cellsig.2022.110248_bb0175","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s004320050161","article-title":"Expression of the active form of MMP-2 on the surface of leukemic cells accounts for their in vitro invasion","volume":"124","author":"Sawicki","year":"1998","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.cellsig.2022.110248_bb0180","first-page":"343","article-title":"Knockdown of c-met inhibits cell proliferation and invasion and increases chemosensitivity to doxorubicin in human multiple myeloma U266 cells in vitro","volume":"4","author":"Que","year":"2011","journal-title":"Mol. Med. Rep."},{"issue":"4","key":"10.1016\/j.cellsig.2022.110248_bb0185","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1089\/adt.2011.391","article-title":"The XTT cell proliferation assay applied to cell layers embedded in three-dimensional matrix","volume":"10","author":"Huyck","year":"2012","journal-title":"Assay Drug Dev. Technol."},{"key":"10.1016\/j.cellsig.2022.110248_bb0190","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/978-1-61779-452-0_15","article-title":"Use of gel zymography to examine matrix metalloproteinase (gelatinase) expression in brain tissue or in primary glial cultures","volume":"814","author":"Frankowski","year":"2012","journal-title":"Meth. Mol. Biol. (Clifton, NJ)"},{"issue":"sup1","key":"10.1016\/j.cellsig.2022.110248_bb0195","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3109\/14756366.2016.1161620","article-title":"Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs","volume":"31","author":"Jablonska-Trypuc","year":"2016","journal-title":"J. Enzyme Inhibit. Med. Chem."},{"issue":"5","key":"10.1016\/j.cellsig.2022.110248_bb0200","first-page":"519","article-title":"Matrix metalloproteinases in bone marrow: roles of gelatinases in physiological hematopoiesis and hematopoietic malignancies","volume":"21","author":"Yu","year":"2006","journal-title":"Histol. Histopathol."},{"issue":"Pt 12","key":"10.1016\/j.cellsig.2022.110248_bb0205","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1093\/brain\/awg285","article-title":"Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosis","volume":"126","author":"Bar-Or","year":"2003","journal-title":"Brain"},{"issue":"12","key":"10.1016\/j.cellsig.2022.110248_bb0210","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1177\/154405910608501202","article-title":"Tissue inhibitors of metalloproteinases (TIMPs): their biological functions and involvement in oral disease","volume":"85","author":"Verstappen","year":"2006","journal-title":"J. Dent. Res."},{"issue":"3","key":"10.1016\/j.cellsig.2022.110248_bb0215","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/sj.gt.3301871","article-title":"Cartilage degradation and invasion by rheumatoid synovial fibroblasts is inhibited by gene transfer of TIMP-1 and TIMP-3","volume":"10","author":"van der Laan","year":"2003","journal-title":"Gene Ther."},{"issue":"1","key":"10.1016\/j.cellsig.2022.110248_bb0220","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12943-017-0616-9","article-title":"A loss of host-derived MMP-7 promotes myeloma growth and osteolytic bone disease in vivo","volume":"16","author":"Lwin","year":"2017","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.cellsig.2022.110248_bb0225","first-page":"26","article-title":"Increased expression of metalloproteinase-2 and -9 (MMP-2, MMP-9), tissue inhibitor of metalloproteinase-1 and -2 (TIMP-1, TIMP-2), and EMMPRIN (CD147) in multiple myeloma","volume":"21","author":"Urbaniak-Kujda","year":"2016","journal-title":"Hematology (Amsterdam, Netherlands)"},{"issue":"Pt 19","key":"10.1016\/j.cellsig.2022.110248_bb0230","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1242\/jcs.00063","article-title":"Metalloproteinase inhibitors: biological actions and therapeutic opportunities","volume":"115","author":"Baker","year":"2002","journal-title":"J. Cell Sci."},{"issue":"2","key":"10.1016\/j.cellsig.2022.110248_bb0235","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1189\/jlb.3MR1116-468R","article-title":"Extracellular matrix and the myeloid-in-myeloma compartment: balancing tolerogenic and immunogenic inflammation in the myeloma niche","volume":"102","author":"Asimakopoulos","year":"2017","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.cellsig.2022.110248_bb0240","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1146\/annurev-cellbio-111315-125227","article-title":"Cellular and molecular mechanisms of MT1-MMP-dependent cancer cell invasion","volume":"32","author":"Castro-Castro","year":"2016","journal-title":"Annu. Rev. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.cellsig.2022.110248_bb0245","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12943-016-0547-x","article-title":"Less is more: low expression of MT1-MMP is optimal to promote migration and tumourigenesis of breast cancer cells","volume":"15","author":"Cepeda","year":"2016","journal-title":"Mol. Cancer"},{"issue":"8","key":"10.1016\/j.cellsig.2022.110248_bb0250","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1158\/1535-7163.MCT-05-0127","article-title":"Competitive disruption of the tumor-promoting function of membrane type 1 matrix metalloproteinase\/matrix metalloproteinase-14 in vivo","volume":"4","author":"Nonaka","year":"2005","journal-title":"Mol. Cancer Ther."},{"issue":"6","key":"10.1016\/j.cellsig.2022.110248_bb0255","article-title":"Constitutive activation of STAT3 in myeloma cells cultured in a three-dimensional","volume":"10","author":"Huang","year":"2018","journal-title":"Reconstruct. Bone Marrow Model"},{"issue":"40","key":"10.1016\/j.cellsig.2022.110248_bb0260","doi-asserted-by":"crossref","first-page":"34123","DOI":"10.1074\/jbc.M508155200","article-title":"Identification of MMP-15 as an anti-apoptotic factor in cancer cells","volume":"280","author":"Abraham","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"28","key":"10.1016\/j.cellsig.2022.110248_bb0265","doi-asserted-by":"crossref","first-page":"9476","DOI":"10.3748\/wjg.v20.i28.9476","article-title":"Establishment of an orthotopic pancreatic cancer mouse model: cells suspended and injected in matrigel","volume":"20","author":"Jiang","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"6","key":"10.1016\/j.cellsig.2022.110248_bb0270","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.3892\/ol.2016.4479","article-title":"Antitumor activity of dobutamine on human osteosarcoma cells","volume":"11","author":"Yin","year":"2016","journal-title":"Oncol. Lett."},{"issue":"45","key":"10.1016\/j.cellsig.2022.110248_bb0275","doi-asserted-by":"crossref","first-page":"17092","DOI":"10.3748\/wjg.v20.i45.17092","article-title":"Inhibitory effects of dobutamine on human gastric adenocarcinoma","volume":"20","author":"Zheng","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"12","key":"10.1016\/j.cellsig.2022.110248_bb0280","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1093\/abbs\/gmw110","article-title":"Antitumor effect of dobutamine on multiple myeloma via mitogen-activated protein kinase pathway in vitro","volume":"48","author":"Xie","year":"2016","journal-title":"Acta Biochim. Biophys. Sin. Shanghai"}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656822000080?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656822000080?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T11:04:02Z","timestamp":1760267042000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656822000080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":56,"alternative-id":["S0898656822000080"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2022.110248","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MT2-MMP is differentially expressed in multiple myeloma cells and mediates their growth and progression","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2022.110248","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110248"}}